Publication | Closed Access

Design and synthesis of highly potent and selective (2-arylcarbamoyl-phenoxy)-acetic acid inhibitors of aldose reductase for treatment of chronic diabetic complications

Medicinal ChemistryDiabetes ManagementAldo-keto ReductaseBiochemistryMedicineAldose ReductaseDiabetes-Acetic Acid InhibitorsNatural SciencesPharmacologyChronic Diabetic ComplicationsDrug Discovery